What Is the Growth Potential of the Predictive Genetic Counselling Market in the Next Decade?
The predictive genetic counselling market size has grown rapidly in recent years. It will grow from $3.60 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to the rising popularity of ancestry and genealogy services, increasing use of genetic data for research purposes, growing demand for paternity and relationship testing, rising application of pharmacogenomics in drug development, and expanding presence of private genetic counselling centers.
The predictive genetic counselling market size is expected to see rapid growth in the next few years. It will grow to $7.59 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to growing integration of artificial intelligence in genetic risk assessment, rising employer-sponsored genetic health programs, increasing partnerships between genetic companies and healthcare providers, growing availability of at-home sample collection kits, and rising demand for reproductive and preconception genetic counselling. Major trends in the forecast period include advancement in multi-omics approaches for comprehensive risk assessment, advanced chatbot-based genetic counselling interfaces, development of blockchain for secure genetic data sharing, innovation in wearable devices linked with genetic health insights, and development of multilingual genetic counselling platforms.
Claim your free report sample now:
What Are the Major Drivers Influencing the Predictive Genetic Counselling Market?
The growing prevalence of genetic disorders is expected to propel the growth of the predictive genetic counselling market going forward. Genetic disorders are conditions that result from changes or defects in a person’s DNA, impacting the body’s growth, development, and overall function. The rise in genetic disorders is due to increasing parental age, as older age at conception is linked to a higher likelihood of genetic mutations in offspring. Genetic disorders support the growth of predictive genetic counselling by increasing the demand for risk assessment services that help individuals understand their likelihood of inheriting or passing on such conditions. For instance, in October 2024, according to the Cystic Fibrosis Trust, a UK-based charitable organization, the number of patients registered with cystic fibrosis rose to 11,318 in 2023, up from 11,148 in 2022. Therefore, the growing prevalence of genetic disorders is driving the predictive genetic counselling market.
Which Segment Holds the Largest Share in the Predictive Genetic Counselling Market?
The predictive genetic counselling market covered in this report is segmented
1) By Service Type: Risk Assessment, Carrier Testing, Predictive Testing, Other Service Types
2) By Mode Of Delivery: In-Person, Online
3) By Application: Consumer Genomics, Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Applications
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Risk Assessment: Family History Evaluation, Lifestyle And Environmental Risk Analysis, Polygenic Risk Score Analysis, Hereditary Disease Susceptibility Screening
2) By Carrier Testing: Cystic Fibrosis Carrier Testing, Tay-Sachs Carrier Testing, Fragile X Syndrome Testing, Sickle Cell Carrier Testing, Thalassemia Carrier Screening
3) By Predictive Testing: Breast Cancer Gene 1 (BRCA1) Or Breast Cancer Gene 2 (BRCA2) Mutation Testing, Lynch Syndrome Testing, Huntington’s Disease Testing, Cardiovascular Genetic Risk Testing, Neurological Disorder Prediction Testing
4) By Other Service Types: Pharmacogenomic Testing, Prenatal Genetic Testing, Newborn Genetic Screening, Direct-To-Consumer Genetic Testing, Whole Genome Sequencing For Prediction
What Are the Key Industry Trends Transforming the Predictive Genetic Counselling Market?
Major companies operating in the predictive genetic counselling market are focusing on developing advanced solutions such as the predictive genetic testing service for early disease risk detection and support for informed clinical decision-making. Predictive genetic testing service refers to a medical service that analyzes an individual's DNA to identify genetic variations associated with an increased risk of developing specific inherited conditions or diseases in the future. For instance, in August 2024, Genetic Technologies Limited, an Australia-based company that provides genomics-based health testing, launched the geneType Risk Assessment test. This test is a unique, comprehensive, multi-risk predictive genetic screening tool designed to assess an individual’s likelihood of developing serious conditions such as breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease, and type 2 diabetes. It combines clinically validated polygenic risk scores with non-genetic factors such as age, family history, and clinical measurements to deliver a personalized, actionable risk profile. It is designed for proactive health management and also provides clear reports with tailored recommendations to guide preventive care and lifestyle choices in over 42 countries.
Which Major Companies Are Operating in the Predictive Genetic Counselling Market?
Major companies operating in the predictive genetic counselling market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Natera Inc, Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, 23andMe Holding Co, Color Genomics Inc, deCODE genetics, Centogene NV, Admera Health LLC, Mapmygenome, Exact Sciences Corporation, BGI Group.
Get the full predictive genetic counselling market report here:
Which Region Is Expected to Lead the Predictive Genetic Counselling Market by 2029?
North America was the largest region in the predictive genetic counselling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic counselling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
Comments
Post a Comment